Related references
Note: Only part of the references are listed.Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders
Vidya Sagar et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Personalized nanomedicine for CNS diseases
Ajeet Kaushik et al.
DRUG DISCOVERY TODAY (2018)
Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery
Ilaria Pezzini et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
Ming Ming Wen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
Elena Sanchez-Lopez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
Maria Gregori et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease
Elisa Conti et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations
Shubham Misra et al.
DRUG DELIVERY (2016)
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
Yang Liu et al.
BIOMATERIALS (2016)
Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment
Joana A. Loureiro et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease
Dongdong Sun et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Improving drug delivery technology for treating neurodegenerative diseases
Yahya E. Choonara et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Safety assessment of nanoparticles for drug delivery by means of classic in vitro assays and beyond
Stefan Lorscheidt et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases
Ivana Cacciatore et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator
Ton Duc Do et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives
Amit Alexander et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Novel nanoparticulate drug delivery systems
Ralf P Friedrich et al.
Nanomedicine (2016)
Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier
Zhi-Lan Chen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
The hunt for brain A beta oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease
Simona Mancini et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art
Govind Soni et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Understanding the Role of Poloxamer 407 based Thermoreversible In Situ Gelling Hydrogel for Delivery of PEGylated Melphalan Conjugate
Amit Alexander et al.
CURRENT DRUG DELIVERY (2016)
Nanoparticle transport across the blood brain barrier
Andreas M. Grabrucker et al.
TISSUE BARRIERS (2016)
Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Jason M. Lajoie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease
Fanfei Meng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Ligand-Appended BBB-Targeted Nanocarriers (LABTNs)
Ankit Jain et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2015)
Safety of Nanoparticles in Medicine
Joy Wolfram et al.
CURRENT DRUG TARGETS (2015)
A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates
Amit Alexander et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: Behavioral and biochemical evidence
Anand Kamal Sachdeva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Nanocarrier-based antioxidant therapy: promise or delusion?
Volkmar Weissig et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies
Pascal U. Richard et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: Preparation and characterization
Sara Laserra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Alzheimer's disease: Potential preventive, non-invasive, intervention strategies in lowering the risk of cognitive decline - A review study
Blanka Klimova et al.
JOURNAL OF APPLIED BIOMEDICINE (2015)
Recent approaches for reducing hemolytic activity of chemotherapeutic agents
Gunjan Jeswani et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease
Maarten Rotman et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a
Sudheesh Pilakka-Kanthikeel et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
Lara Ordonez-Gutierrez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer's Disease
Xiaoyao Zheng et al.
PHARMACEUTICAL RESEARCH (2015)
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Alejandro Baeza et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Targeting delivery of liposomes with conjugated p-aminophenyl-α-D-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide
Yung-Chih Kuo et al.
JOURNAL OF DRUG TARGETING (2015)
Nanoemulsion: an advanced mode of drug delivery system
Manjit Jaiswal et al.
3 BIOTECH (2015)
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
Saba Khan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2015)
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Chi Zhang et al.
BIOMATERIALS (2014)
Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin
Yung-Chih Kuo et al.
BIOMATERIALS (2014)
Characterization of New Specific Copper Chelators as Potential Drugs for the Treatment of Alzheimer's Disease
Michel Nguyen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease
Spyridon Mourtas et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of a dual nanocarrier system as a potential stratagem against amyloid- induced toxicity
Priyadharshini Kumaraswamy et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Nanostructured liquid-crystalline particles for drug delivery
Alexandre Lancelot et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems
Rajesh Sunasee et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Nanotechnology-based drug delivery systems and herbal medicines: a review
Bruna Vidal Bonifacio et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease
Chi Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats
Jaap Rip et al.
JOURNAL OF DRUG TARGETING (2014)
Multifunctional Liposomes Reduce Brain β-Amyloid Burden and Ameliorate Memory Impairment in Alzheimer's Disease Mouse Models
Claudia Balducci et al.
JOURNAL OF NEUROSCIENCE (2014)
A Novel Oil-Body Nanoemulsion Formulation of Ginkgolide B: Pharmacokinetics Study and In Vivo Pharmacodynamics Evaluations
Pengfei Yang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Neuroprotection Against Degeneration of SK-N-MC Cells Using Neuron Growth Factor-Encapsulated Liposomes with Surface Cereport and Transferrin
Yung-Chih Kuo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate
Amit Alexander et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease
Laura Bana et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Michal Mizrahi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Nanogel carrier design for targeted drug delivery
D. M. Eckmann et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease
Serge Gauthier et al.
ALZHEIMERS & DEMENTIA (2013)
Incorporation of β-sitosterol into the membrane increases resistance to oxidative stress and lipid peroxidation via estrogen receptor-mediated PI3K/GSK3β signaling
Chun Shi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Clawing back: broadening the notion of metal chelators in medicine
Katherine J. Franz
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease
Piera Sozio et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles
Medha Patel et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB
Kalpana Nagpal et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease
Manal Fouad Ismail et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
Pratikkumar A. Patel et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration
Zhen-Zhen Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Formulation and Characterization of Nanostructured Lipid Carrier of Ubiquinone (Coenzyme Q10)
Basavaraj K. Nanjwade et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications
Amit Alexander et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model
Mohammad Yusuf et al.
JOURNAL OF DRUG TARGETING (2013)
Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study
Annika Lindqvist et al.
MOLECULAR PHARMACEUTICS (2013)
Multistep Targeted Nano Drug Delivery System Aiming at Leukemic Stem Cells and Minimal Residual Disease
Yongping Shi et al.
MOLECULAR PHARMACEUTICS (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prions, prionoids and pathogenic proteins in Alzheimer disease
Karen H. Ashe et al.
PRION (2013)
PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer's Disease
Davide Brambilla et al.
ACS NANO (2012)
4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies
Marzia Perluigi et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Anti-glioma Effect and Safety of Docetaxel-loaded Nanoemulsion
Huil Gaoe et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Anu Puri et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Potential Approaches for Drug Delivery to the Brain: Past, Present, and Future
Vandana Soni et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics
Amit K. Jain et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes
Weize Li et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Advancement in stimuli triggered in situ gelling delivery for local and systemic route
Ajazuddin et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin
Chandana Mohanty et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
Fulan Xie et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Approaches for breaking the barriers of drug permeation through transdermal drug delivery
Amit Alexander et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Transport of drugs across the blood-brain barrier by nanoparticles
Stefanie Wohlfart et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanobiotechnology-based strategies for crossing the blood-brain barrier
Kewal K. Jain
NANOMEDICINE (2012)
Effect of Phenolic Compounds Against Aβ Aggregation and Aβ-Induced Toxicity in Transgenic C. elegans
Seema Jagota et al.
NEUROCHEMICAL RESEARCH (2012)
Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model
Sylvia Wagner et al.
PLOS ONE (2012)
Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
Eric A. Tanifum et al.
PLOS ONE (2012)
Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain Delivery
Yuan Yu et al.
PHARMACEUTICAL RESEARCH (2012)
Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
Benjamin W. Miller et al.
ANNALS OF PHARMACOTHERAPY (2011)
The history of the cholinergic hypothesis
Antonio Contestabile
BEHAVIOURAL BRAIN RESEARCH (2011)
Endoplasmic reticulum stress enhances γ-secretase activity
Kazunori Ohta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Spyridon Mourtas et al.
BIOMATERIALS (2011)
Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems
Hongfei Wu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Drug delivery strategies for Alzheimer's disease treatment
Antonio Di Stefano et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
Jasjeet Kaur Sahni et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
Sanju Dhawan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain
Gobinda Sarkar et al.
PLOS ONE (2011)
Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
Yael Friedman-Levi et al.
PLOS PATHOGENS (2011)
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
Ho Lun Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery
Huali Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor
Qian Xiao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles
Barbara Luppi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery
Nicolas Duceppe et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
Adam Smith et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease
Caterina M. Hernandez et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced skin delivery of quercetin by microemulsion
Shuji Kitagawa et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
Rupa R. Sawant et al.
MOLECULAR MEMBRANE BIOLOGY (2010)
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution
Maria Luisa Bondi et al.
NANOMEDICINE (2010)
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine
Barnabas Wilson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Adriano Aguzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design
Jaleh Varshosaz et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2010)
Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
Xiao-xia Dong et al.
ACTA PHARMACOLOGICA SINICA (2009)
The binding of pullulan modified cholesteryl nanogels to Aβ oligomers and their suppression of cytotoxicity
Sebastien Boridy et al.
BIOMATERIALS (2009)
Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cells
Chun Shi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Cross Currents in Protein Misfolding Disorders: Interactions and Therapy
Rodrigo Morales et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimer's Disease: Preparation, Characterization and Cytotoxicity Studies
M. L. Bondi et al.
CURRENT NANOSCIENCE (2009)
Quantifying drug release from PLGA nanoparticulates
Owen I. Corrigan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier
Eugen Barbu et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Differential receptor-mediated drug targeting to the diseased brain
J. Rip et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System
S. Mukherjee et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Jana Pardeike et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Lipid nanocapsules: A new platform for nanomedicine
N. T. Huynh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin
Jong Oh Kim et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
Kaili Hu et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer's disease
Mubeen Ahmad Ansari et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Delivery of peptide and protein drugs over the blood-brain barrier
Ivona Brasnjevic et al.
PROGRESS IN NEUROBIOLOGY (2009)
Self-assembled cationic nanogels for intracellular protein delivery
Hirohito Ayame et al.
BIOCONJUGATE CHEMISTRY (2008)
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain
Rongqin Huang et al.
BIOMATERIALS (2008)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
Barnabas Wilson et al.
BRAIN RESEARCH (2008)
Polymeric nanoparticles for the drug delivery to the central nervous system
Giovanni Tosi et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties
Fonghsu Kuo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Research on the chelation between quercetin and Cr(III) ion by Density Functional Theory (DFT) method
Shaofang Sun et al.
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2008)
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N. Begum et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Solid lipid nanoparticles as delivery systems for bromocriptine
Elisabetta Esposito et al.
PHARMACEUTICAL RESEARCH (2008)
Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy
Edward K. Agyare et al.
PHARMACEUTICAL RESEARCH (2008)
Pomegranate oil analysis with emphasis on MALDI-TOF/MS triacylglycerol fingerprinting
Maya Kaufman et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials
Roberto Raschetti et al.
PLOS MEDICINE (2007)
Preparation and characterization of a novel nonviral gene transfer system: Procationic-liposome-protamine-DNA complexes
Zhi-Rong Zhong et al.
DRUG DELIVERY (2007)
Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
Rong-qin Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2007)
Strategies to improve drug delivery across the blood-brain barrier
Albertus G. de Boer et al.
CLINICAL PHARMACOKINETICS (2007)
Drug targeting to the brain
William M. Pardridge
PHARMACEUTICAL RESEARCH (2007)
Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones
Keisuke Ikeda et al.
FEBS LETTERS (2006)
Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice
Vipan Kumar Parihar et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2006)
Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?
Yaming Su et al.
EXPERT OPINION ON DRUG DELIVERY (2006)
Development and evaluation of sesamol as an antiaging agent
S Sharma et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Formulation of drugs in block copolymer micelles: Drug loading and release
J. Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Neuroprotective therapies for Alzheimer's disease
A Huber et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells
RCW Hou et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system
FQ Hu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2005)
Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry
F Castelli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Mammalian lactoferrin receptors:: structure and function
YA Suzuki et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
W Lu et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor
Y Aktas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Photoprotective effect of sesamol on UVB-radiation induced oxidative stress in human blood lymphocytes in vitro
NR Prasad et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2005)
Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: Interaction with proteins and chaperone-like activity
N Morimoto et al.
BIOMACROMOLECULES (2005)
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Y Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
ZR Cui et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Modulation of neurodegeneration by molecular chaperones
PJ Muchowski et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain
J Kreuter
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2004)
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy
K Jores et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Passiflora:: a review update
K Dhawan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice
JD Lambert et al.
JOURNAL OF NUTRITION (2004)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
SA Agnihotri et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Alzheimer's disease pathogenesis and therapeutic interventions
MS Parihar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
Solid lipid nanoparticles for parenteral drug delivery
SA Wissing et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
Amyloid-β:: a chameleon walking in two worlds:: a review of the trophic and toxic properties of amyloid-β
CS Atwood et al.
BRAIN RESEARCH REVIEWS (2003)
A review of rivastigmine: A reversible cholinesterase inhibitor
BR Williams et al.
CLINICAL THERAPEUTICS (2003)
Metal binding and oxidation of amyloid-β within isolated senile plaque cores:: Raman microscopic evidence
J Dong et al.
BIOCHEMISTRY (2003)
Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters
P Shahgaldian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse:: implications for targeting β-amyloid in Alzheimer's disease
W Härtig et al.
NEUROSCIENCE LETTERS (2003)
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid
SJ Lim et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Nanostructured lipid matrices for improved microencapsulation of drugs
RH Müller et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Synthesis of pegylated immunonanoparticles
JC Olivier et al.
PHARMACEUTICAL RESEARCH (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
Nanoparticulate systems for brain delivery of drugs
J Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2001)
Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease
A Maelicke et al.
BIOLOGICAL PSYCHIATRY (2001)
Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease
RA Cherny et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Interactions between ascorbyl free radical and coenzyme Q at the plasma membrane
A Arroyo et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2000)
Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats
RH Wang et al.
NEUROPHARMACOLOGY (2000)
Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system
A Friese et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Share Paper
